ahlam1399
05-23-2015, 01:32 AM
Amgen ends collaboration with AstraZeneca on inflammation drug
May 22 (Reuters) - Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46916800/sc/21/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=ACm6LQRBakU:v28dgdAW_yY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ACm6LQRBakU:v28dgdAW_yY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=ACm6LQRBakU:v28dgdAW_yY:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ACm6LQRBakU:v28dgdAW_yY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=ACm6LQRBakU:v28dgdAW_yY:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/ACm6LQRBakU
May 22 (Reuters) - Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46916800/sc/21/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=ACm6LQRBakU:v28dgdAW_yY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ACm6LQRBakU:v28dgdAW_yY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=ACm6LQRBakU:v28dgdAW_yY:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ACm6LQRBakU:v28dgdAW_yY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=ACm6LQRBakU:v28dgdAW_yY:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/ACm6LQRBakU